Apelin/APJ signaling has been shown to be proangiogenic and provide beneficial outcomes in response to myocardial infarction in rats [41] whereas apelin levels are reduced in diseased murine and human hearts, increasing their susceptibility to myocardial ischemia-induced damage [42]. This evidence concerns the gene APLN and myocardial infarction.